Novogene Competitors and Similar CompaniesClear all

Novogene's competitors and similar companies include MGI, Lysogene and Access Biologicals.

	Novogene Novogene (北京诺禾致源科技股份有限公司) is a company specializing in genomics and bioinformatics research solutions.	MGI MGI Tech (深圳华大智造科技股份有限公司) is a company that provides core tools and technologies in life science.	Lysogene Lysogene is a company that provides research and clinical development of gene therapy for neurodegenerative disorders.	Access Biologicals Access Biologicals is a biomanufacturing company producing blood and plasma-based biological products.
Founding Date	Founding Date 2011	Founding Date 2016	Founding Date 2009	Founding Date 2006
Type	Type Public	Type Public	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech genetics life sciences medical diagnostics pharma	Tags Manufacturing & Industrial automation biotech genetics life sciences medical diagnostics medical imaging	Tags Healthcare biotech genetics medical diagnostics pharma	Tags Healthcare biotech life sciences medical diagnostics pharma
Locations	Locations Beijing, CN HQ Planegg, DE Hong Kong, HK Tokyo, JP Seoul, KR Singapore, SG Cambridge, GB see more	Locations Shenzhen, CN HQ Herston, AU São Paulo, BR Qingdao, CN Wuhan, CN Wehrheim, DE Hong Kong, HK see more	Locations Neuilly-sur-Seine, FR HQ Cambridge, US	Locations Vista, US HQ Dartmouth, US
Employees	Employees 2,2023% increase	Employees 2,6049% decrease	Employees 22	Employees 37
Financial
Revenue (est.)	Revenue (est.) ¥2.2b (FY, 2025)	Revenue (est.) ¥2.7b (FY, 2025)	Revenue (est.) €3.7m (FY, 2021)	Revenue (est.) N/A
Cost of goods	Cost of goods ¥1.3b (FY, 2025)	Cost of goods ¥1.3b (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit ¥934.7m (FY, 2025)	Gross profit ¥1.5b (FY, 2025)	Gross profit €7.2m (FY, 2021)	Gross profit N/A
Net income	Net income ¥171.5m (FY, 2025)	Net income (¥221.9m) (FY, 2025)	Net income (€13.6m) (FY, 2021)	Net income N/A